A meta-analysis of effects of selective serotonin reuptake inhibitors on blood pressure in depression treatment: outcomes from placebo and serotonin and noradrenaline reuptake inhibitor controlled trials
Open accessThe DOI matches its Crossref record; 61 of the 63 references it cites were found in a registry or an index.
Abstract
Background: Selective serotonin reuptake inhibitors (SSRIs) and serotonin and noradrenaline reuptake inhibitors (SNRIs) have been commonly prescribed for depression treatment. However, their effects on blood pressure are unclear. Materials and methods: Effects on blood pressure of depressive patients in two groups (SSRIs versus placebo and SSRIs versus SNRIs) were evaluated. A search was conducted for double-blind, randomized controlled trials (RCTs) in PubMed, EMBASE, ISI Web of Science, PsycNET, CCRCT, and DARE (up to March 2017). The outcomes were systolic blood pressure (SBP) changes and diastolic blood pressure (DBP) changes from baseline to endpoint or to a certain period of treatment duration. Weighted mean differences (WMDs) and 95% CIs were calculated and pooled using random effects models. The χ 2 test and I 2 statistics were used to assess heterogeneity. Funnel plots, Begg’s test, and Egger’s test were used to estimate publication bias. Results: A total of 23 RCTs involving 13,285 participants were included. Patients on SSRIs showed no significant differences in blood pressure changes compared with placebo. In the group of SSRIs versus SNRIs, overall SBP changes and DBP changes revealed statistical significances (WMD 1.5 mmHg, 95% CI -2.15, -0.84, Z =4.46, P <0.00001 and WMD 1.34 mmHg, 95% CI -1.92, -0.75, Z =6.18, P <0.00001). Subgroup analyses on treatment duration and age further evidenced these findings. Conclusion: It was established that SSRIs did not affect blood pressure, while SNRIs led to a modest increase in SBP and DBP with statistical significance compared with SSRIs. Keywords: meta-analysis, blood pressure change, depression treatment, selective serotonin reuptake inhibitors, serotonin and noradrenaline reuptake inhibitors, depression, antidepressant, systolic blood pressure, diastolic blood pressure
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures











Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“2/1 mm Hg increase with SNRI (selective norepinephrine and serotonin reuptake inhibitors)”
From 2020 International Society of Hypertension Global Hypertension Practice Guidelines (2020) · cites this paper as [38]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Increased odds ratio of 3.19 of hypertension with tricyclic antidepressant”
From 2020 International Society of Hypertension Global Hypertension Practice Guidelines (2020) · cites this paper as [38]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“3/1 mm Hg increase with nonselective NSAIDs”
From 2020 International Society of Hypertension Global Hypertension Practice Guidelines (2020) · cites this paper as [38]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“NSAIDs can antagonize the effects of RAAS-inhibitors and beta blockers”
From 2020 International Society of Hypertension Global Hypertension Practice Guidelines (2020) · cites this paper as [38]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“No increase in blood pressure with aspirin”
From 2020 International Society of Hypertension Global Hypertension Practice Guidelines (2020) · cites this paper as [38]
Experimental — accuracy not yet measured
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cipriani, A., Furukawa, T. A., Salanti, G., Geddes, J. R., Higgins, J. P., Churchill, R., Watanabe, N., Nakagawa, A., Omori, I. M., McGuire, H., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60046-5 · Cited by 1,654
Sertraline treatment of major depression in patients with acute MI or unstable angina.
Glassman, A., O’Connor, C., Califf, R., Swedberg, K., Schwartz, P., Bigger, J., Krishnan, K., van Zyl, L. V., Swenson, J., Finkel, M., et al. (2002) · Journal of the American Medical Association (JAMA) · doi:10.1016/s1062-1458(02)00908-x · Cited by 1,494 · cited 1×
“One study included patients with MDD combined with a history of acute myocardial infarction or unstable angina.(20) Two trials were about MDD combined with coronary artery disease(28) or depressive disorders combined with acute coronary syndrome,(33) respectively.”
Sertraline treatment of major depression in patients with acute MI or unstable angina
Glassman, A. H. (2002) · JAMA · doi:10.1001/jama.288.6.701 · Cited by 1,414
Kemp, A. H., Quintana, D. S., Gray, M. A., Felmingham, K. L., Brown, K., & Gatt, J. M. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.12.012 · Cited by 1,286 · cited 2×
“Depression is associated with reductions in heart rate variability(42) and might be related to low cardiac vagal control,(43) as well as central autonomic dysfunction, a shift of autonomic balance toward sympathetic predominance, leading to cardiovascular somatic symptoms of depression such as higher heart rate and BP…”
Kario, K., Pickering, T. G., Umeda, Y., Hoshide, S., Hoshide, Y., Morinari, M., Murata, M., Kuroda, T., Schwartz, J. E., & Shimada, K. (2003) · Circulation · doi:10.1161/01.cir.0000056521.67546.aa · Cited by 1,250 · cited 1×
“Prior studies have shown that a higher morning BP surge is positively correlated with depressive symptoms(54) and is associated with stroke risk independently in older hypertensive patients.(55) Low-frequency component of systolic BPV, a surrogate of sympathetic vasomotor tone, can show blunted response with depressiv…”
Brent, D., Emslie, G., Clarke, G., Wagner, K. D., Asarnow, J. R., Keller, M., Vitiello, B., Ritz, L., Iyengar, S., Abebe, K., et al. (2008) · JAMA · doi:10.1001/jama.299.8.901 · Cited by 700 · cited 1×
“26 Emslie et al 2014 29,a Emslie et al 2014 29 , b Emslie et al 2015 30 Atkinson et al 2014 40 Oslin et al 2003 24”
Lespérance, F., Frasure-Smith, N., Koszycki, D., Laliberté, M.-A., van Zyl, L. T., Baker, B., Swenson, J. R., Ghatavi, K., Abramson, B. L., Dorian, P., et al. (2007) · JAMA · doi:10.1001/jama.297.4.367 · Cited by 658
Depression and the Link with Cardiovascular Disease
Dhar, A. K., & Barton, D. A. (2016) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2016.00033 · Cited by 400 · cited 2×
“Depression deregulates hypothalamic–pituitary–adrenal axis when depressive people are experiencing psychological stress.(2) As SSRIs and SNRIs improve the stressful condition, we speculate that they can play a role in hypothalamic–”
Cohen, H. W., Gibson, G., & Alderman, M. H. (2000) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)00301-0 · Cited by 390 · cited 1×
“It is reported that SSRIs can affect cardiovascular function.(16) SSRIs are rarely associated with cardiac death but cause side effects such as hypotension and mild bradycardia.”
Cardiac vagal control in depression: A critical analysis
Rottenberg, J. (2007) · Biological Psychology · doi:10.1016/j.biopsycho.2005.08.010 · Cited by 376 · cited 2×
“Depression is associated with reductions in heart rate variability 42 and might be related to low cardiac vagal control, 43 as well as central autonomic dysfunction, a shift of autonomic balance toward sympathetic predominance, leading to cardiovascular somatic symptoms of depression such as higher…”
Thase, M. E. (1998) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v59n1002 · Cited by 331 · cited 4×
“Incidence of clinically significant increases in BP can be lower at doses below 200 mg daily, 13 and only doses above 300 mg/day lead to statistical and clinical significance of the incidence of elevated supine DBP. 14 A previous study reported that duloxetine at suprath-erapeutic doses increases supine SBP and DBP by…”
InfluentialDepression and Cardiac Disease: A Review
Celano, C. M., & Huffman, J. C. (2011) · Cardiology in Review · doi:10.1097/crd.0b013e31820e8106 · Cited by 320 · cited 1×
“Worldwide, 17% of people are likely to experience major depression during their lifetime; it is especially prevalent in patients with cardiovascular disorders.(1) It is well established that depressive patients tend to have unhealthy lifestyles including smoking, physical inactivity, and poor medication adherence.”
Licht, C. M. M., de Geus, E. J. C., Seldenrijk, A., van Hout, H. P. J., Zitman, F. G., van Dyck, R., & Penninx, B. W. J. H. (2009) · Hypertension · doi:10.1161/hypertensionaha.108.126698 · Cited by 319
Goldstein, D. J., Lu, Y., Detke, M. J., Wiltse, C., Mallinckrodt, C., & Demitrack, M. A. (2004) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000132448.65972.d9 · Cited by 314
Sympathetic activity in major depressive disorder: identifying those at increased cardiac risk?
Barton, D. A., Dawood, T., Lambert, E. A., Esler, M. D., Haikerwal, D., Brenchley, C., Socratous, F., Kaye, D. M., Schlaich, M. P., Hickie, I., et al. (2007) · Journal of Hypertension · doi:10.1097/hjh.0b013e32829baae7 · Cited by 291 · cited 1×
“Furthermore, sympathetic activity may be attenuated by administration of SSRIs in major depressive patients,(46,47) thus reducing cardiac risk to some degree.(46) Sertraline has been demonstrated to decrease sympathetic tone of patients with depression in conditions of physiological stress,(47) and it may be an approp…”
Detke, M. J., Wiltse, C. G., Mallinckrodt, C. H., McNamara, R. K., Demitrack, M. A., & Bitter, I. (2004) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2004.01.002 · Cited by 282
Scalco, A. Z., Scalco, M. Z., Azul, J. B. S., & Neto, F. L. (2005) · Clinics · doi:10.1590/s1807-59322005000300010 · Cited by 257
Yan, J., Pan, Y., Cai, W., Cheng, Q., Dong, W., & An, T. (2015) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s77710 · Cited by 254 · cited 1×
“In contrast, a meta-analysis suggests anxiety and hypertension are significantly correlated, drawing the conclusion that anxiety is an independent risk factor for incident hypertension.(7) Anxiety and depression are closely linked.”
Croft, H., Settle, E., Houser, T., Batey, S. R., Donahue, R. M. J., & Ascher, J. A. (1999) · Clinical Therapeutics · doi:10.1016/s0149-2918(00)88317-4 · Cited by 242
Maayan, L., Vakhrusheva, J., & Correll, C. U. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.21 · Cited by 230 · cited 1×
“In the absence of data from authors, we used the average SDs of other studies with the same medication.(18) We evaluated study heterogeneity by χ(2) test and I 2 statistics, with statistical significance set at χ(2) P,0.”
Pizzi, C., Rutjes, A. W. S., Costa, G. M., Fontana, F., Mezzetti, A., & Manzoli, L. (2011) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2010.11.017 · Cited by 203 · cited 1×
“With the existence of the hypothesis that BP can partly explain the association between cardiovascular disease and psychopathology, SSRIs may be more suitable than SNRIs because of improvement in CHD prognosis for depressive patients with CHD.(50) The included trials recorded office BP, which showed the incapability t…”
Autonomy of Autonomic Dysfunction in Major Depression
Koschke, M., Boettger, M. K., Schulz, S., Berger, S., Terhaar, J., Voss, A., Yeragani, V. K., & Bär, K.-J. (2009) · Psychosomatic Medicine · doi:10.1097/psy.0b013e3181b8bb7a · Cited by 199 · cited 2×
“Depression is associated with reductions in heart rate variability(42) and might be related to low cardiac vagal control,(43) as well as central autonomic dysfunction, a shift of autonomic balance toward sympathetic predominance, leading to cardiovascular somatic symptoms of depression such as higher heart rate and BP…”
Coleman, C. (2001) · Clinical Therapeutics · doi:10.1016/s0149-2918(01)80090-4 · Cited by 179
Bielski, R. J., Ventura, D., & Chang, C.-C. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0906 · Cited by 178
Association of low blood pressure with anxiety and depression: the Nord-Trøndelag Health Study
Hildrum, B., Mykletun, A., Stordal, E., Bjelland, I., Dahl, A. A., & Holmen, J. (2007) · Journal of Epidemiology and Community Health · doi:10.1136/jech.2005.044966 · Cited by 162
Effect of anxiety and depression on blood pressure: 11-year longitudinal population study
Hildrum, B., Mykletun, A., Holmen, J., & Dahl, A. A. (2008) · British Journal of Psychiatry · doi:10.1192/bjp.bp.107.045013 · Cited by 155 · cited 1×
“This association is not explained by the use of antidepressants or antihypertensive medications.(5) The Three City Study confirms that both depressed men and women have lower systolic blood pressure (SBP) and diastolic blood pressure (DBP), which are unrelated to antihypertensive or psychotropic agents.”
Cardiovascular safety in depressed patients: focus on venlafaxine.
Feighner, J. P. (1995) · PubMed · Cited by 143
Nierenberg, A. A., Greist, J. H., Mallinckrodt, C. H., Prakash, A., Sambunaris, A., Tollefson, G. D., & Wohlreich, M. M. (2007) · Current Medical Research and Opinion · doi:10.1185/030079906x167453 · Cited by 131
Duloxetine in the treatment of major depressive disorder: a placebo- and paroxetine-controlled trial
Perahia, D. G. S., Wang, F., Mallinckrodt, C. H., Walker, D. J., & Detke, M. J. (2006) · European Psychiatry · doi:10.1016/j.eurpsy.2006.03.004 · Cited by 128
Oslin, D. W., Have, T. R. T., Streim, J. E., Datto, C. J., Weintraub, D., DiFilippo, S., & Katz, I. R. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n0804 · Cited by 116 · cited 1×
“26 Emslie et al 2014 29,a Emslie et al 2014 29 , b Emslie et al 2015 30 Atkinson et al 2014 40 Oslin et al 2003 24”
Emslie, G. J., Prakash, A., Zhang, Q., Pangallo, B. A., Bangs, M. E., & March, J. S. (2014) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2013.0096 · Cited by 106 · cited 1×
“26 Emslie et al 2014 29,a Emslie et al 2014 29 , b Emslie et al 2015 30 Atkinson et al 2014 40 Oslin et al 2003 24”
Allard, P., Gram, L., Timdahl, K., Behnke, K., Hanson, M., & Søgaard, J. (2004) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.1190 · Cited by 105
Wade, A., Gembert, K., & Florea, I. (2007) · Current Medical Research and Opinion · doi:10.1185/030079907x210732 · Cited by 102
Safety of Antidepressant Drugs in the Patient with Cardiac Disease: A Review of the Literature
Alvarez, W., & Pickworth, K. K. (2003) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.23.6.754.32185 · Cited by 84
Atkinson, S. D., Prakash, A., Zhang, Q., Pangallo, B. A., Bangs, M. E., Emslie, G. J., & March, J. S. (2014) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2013.0146 · Cited by 80 · cited 1×
“26 Emslie et al 2014 29,a Emslie et al 2014 29 , b Emslie et al 2015 30 Atkinson et al 2014 40 Oslin et al 2003 24”
Nemeroff, C. B., & Thase, M. E. (2005) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2005.07.009 · Cited by 76
Muscle sympathetic nervous activity in depressed patients before and after treatment with sertraline
Scalco, A. Z., Rondon, M. U., Trombetta, I. C., Laterza, M. C., Azul, J. B., Pullenayegum, E. M., Scalco, M. Z., Kuniyoshi, F. H., Wajngarten, M., Negrão, C. E., et al. (2009) · Journal of Hypertension · doi:10.1097/hjh.0b013e3283310ece · Cited by 75
Relationship between blood pressure and depression in the elderly. The Three-City Study
Lenoir, H., Lacombe, J., Dufouil, C., Ducimetière, P., Hanon, O., Ritchie, K. A., Dartigues, J., Alpérovitch, A., & Tzourio, C. (2008) · Journal of Hypertension · doi:10.1097/hjh.0b013e3283088d1f · Cited by 71 · cited 1×
“The Three City Study confirms that both depressed men and women have lower systolic blood pressure (SBP) and diastolic blood pressure (DBP), which are unrelated to antihypertensive or psychotropic agents.(6) In contrast, a meta-analysis suggests anxiety and hypertension are significantly correlated, drawing the conclu…”
Kim, J.-M., Bae, K.-Y., Stewart, R., Jung, B.-O., Kang, H.-J., Kim, S.-W., Shin, I.-S., Hong, Y. J., Kim, J. H., Shin, H.-Y., et al. (2015) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.14m09281 · Cited by 71
Lenox-Smith, A. J., & Jiang, Q. (2008) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e3282f424c2 · Cited by 64 · cited 1×
“There were 23 non-duplicated trials 19– 41 comparing SSRI intervention with placebo or SNRIs included for this meta-analysis , after”
The cardiovascular safety profile of escitalopram
Thase, M. E., Larsen, K. G., Reines, E. H., & Kennedy, S. H. (2013) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2013.05.011 · Cited by 59 · cited 3×
“Escitalopram results in a slight decrease in BP without dose effect, though not clinically meaningful.(11) Furthermore, it has been reported that a modest reduction in SBP and DBP could be observed when statistically comparing fluoxetine with placebo during shortterm treatment.”
Gender-dependent impact of major depression on autonomic cardiovascular modulation
Voss, A., Boettger, M. K., Schulz, S., Gross, K., & Bär, K. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2011.03.015 · Cited by 56 · cited 1×
“Moreover, BPV is more sensitive in reflecting depressionassociated changes of autonomic function as compared to heart rate variability.(53) Prior studies have shown that a higher morning BP surge is positively correlated with depressive symptoms(54) and is associated with stroke risk independently in older hypertensiv…”
Blood Pressure Changes During Short-Term Fluoxetine Treatment
Amsterdam, J. D., Garcia-Espana, F., Fawcett, J., Quitkin, F. M., Reimherr, F. W., Rosenbaum, J. F., & Beasley, C. (1999) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199902000-00004 · Cited by 51 · cited 1×
“Furthermore, it has been reported that a modest reduction in SBP and DBP could be observed when statistically comparing fluoxetine with placebo during shortterm treatment.(12) Effects of venlafaxine and duloxetine on BP have been depicted in previous studies.”
LEE, P., SHU, L., XU, X., WANG, C. Y., LEE, M. S., LIU, C., HONG, J. P., RUSCHEL, S., RASKIN, J., COLMAN, S. A., et al. (2007) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2007.01666.x · Cited by 50
Keller, M. B., Trivedi, M. H., Thase, M. E., Shelton, R. C., Kornstein, S. G., Nemeroff, C. B., Friedman, E. S., Gelenberg, A. J., Kocsis, J. H., Dünner, D. L., et al. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.04.040 · Cited by 49
Stockman, J. A. (2009) · Yearbook of Pediatrics · doi:10.1016/s0084-3954(08)79063-8 · Cited by 48
Nelson, J. C., Lu Pritchett, Y., Martynov, O., Yu, J. Y., Mallinckrodt, C. H., & Detke, M. J. (2006) · The Primary Care Companion For CNS Disorders · doi:10.4088/pcc.v08n0404 · Cited by 44
Selective serotonin reuptake inhibitors and cardiovascular events: A systematic review
Nezafati, M. H., Eshraghi, A., Vojdanparast, M., Abtahi, S., & Nezafati, P. (2016) · Journal of Research in Medical Sciences · doi:10.4103/1735-1995.189647 · Cited by 44 · cited 1×
“SSRIs are rarely associated with cardiac death but cause side effects such as hypotension and mild bradycardia.(17) SNRIs can cause elevation of BP, particularly of DBP.”
The Effects of Supratherapeutic Doses of Duloxetine on Blood Pressure and Pulse Rate
Derby, M. A., Zhang, L., Chappell, J. C., Gonzales, C. R., Callaghan, J. T., Leibowitz, M., Ereshefsky, L., Hoelscher, D., Leese, P. T., & Mitchell, M. I. (2007) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e31804d1cce · Cited by 36 · cited 1×
“A previous study reported that duloxetine at supratherapeutic doses increases supine SBP and DBP by maxima of ~12 mmHg and 7 mmHg above baseline, respectively.(15) Doses of venlafaxine and duloxetine in the included trials of our analysis varied between 75–375 mg/d and 40–120 mg/d, respectively.”
Depression and anxiety in the developing world: is it time to medicalise the suffering?
Stein, D. J., & Gureje, O. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16693-2 · Cited by 35 · cited 1×
“8 A previous review also showed an increased risk of hypertension in depressed patients and an increased risk of depression in hypertensive patients.”
Sanchez-Gonzalez, M. A., May, R. W., Koutnik, A. P., Kabbaj, M., & Fincham, F. D. (2013) · American Journal of Hypertension · doi:10.1093/ajh/hpt131 · Cited by 33 · cited 1×
“In addition, some studies suggest low-frequency component of systolic BPV may be a potential biomarker of neurovascular functioning, contributing to a better understanding of the interaction between MDD and cardiovascular disease.(56) It has been reported that fluvoxamine has a potency to diminish autonomic cardiac ac…”
Dj, G., Bitter, I., Lu, Y., Detke, M. J., Wiltse, C. G., Mallinckrodt, C. H., & Demitrack, M. A. (2002) · European Psychiatry · doi:10.1016/s0924-9338(02)80446-1 · Cited by 31
Does the control of negative emotions influence blood pressure control and its variability?
Symonides, B., Holas, P., Schram, M., Śleszycka, J., Bogaczewicz, A., & Gaciong, Z. A. (2014) · Blood Pressure · doi:10.3109/08037051.2014.901006 · Cited by 27 · cited 1×
“The included trials recorded office BP, which showed the incapability to reveal the circadian BP rhythm.(51) There is research indicating that even a mildly depressive mood is associated with larger among-day BP variability (BPV).”
Sheehan, D. V., Nemeroff, C. B., Thase, M. E., & Entsuah, R. (2009) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e32831980f2 · Cited by 27
(2004) · Pharmacopsychiatry · doi:10.1055/s-2004-815470 · Cited by 27 · cited 1×
“It has been reported that fluvoxamine has a potency to diminish autonomic cardiac activity, and both pharmacological actions and improvement of depressive mood state could change BP level after antidepressant treatment.(57) However, antidepressant medication studies N eu ro ps yc hi at ric D is ea se a nd T re at m en…”
Depression and cardiovascular risk: does blood pressure play a role?
Scuteri, A. (2008) · Journal of Hypertension · doi:10.1097/hjh.0b013e32830dfff7 · Cited by 23 · cited 1×
“of depression, have been reported to have a higher occurrence of morbidity and mortality for cardiovascular events.(3) Some studies indicate that low blood pressure (BP) is associated with increased prevalence of depression, as well as with depressive symptom severity, which is independent of age, sex, or cardiovascul…”
Okajima, K., Yamanaka, G., Oinuma, S., Kikichi, T., Yamanaka, T., Otsuka, K., & Cornélissen, G. (2015) · Clinical and Experimental Hypertension · doi:10.3109/10641963.2015.1013114 · Cited by 17
Emslie, G. J., Wells, T. G., Prakash, A., Zhang, Q., Pangallo, B. A., Bangs, M. E., & March, J. S. (2015) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2014.0076 · Cited by 15 · cited 2×
“In addition, this greater increase in BP from baseline in SNRI-treated patients compared with SSRI-treated patients is consistent with the pharmacological actions, which are actions on both serotonergic and noradrenergic neurotransmission and on serotonergic neurotransmission.(30) A 3 mmHg difference in SBP may be tho…”
Effects of dipping and psychological traits on morning surge in blood pressure in healthy people
FitzGerald, L., Ottaviani, C., Goldstein, I. B., & Shapiro, D. (2011) · Journal of Human Hypertension · doi:10.1038/jhh.2011.34 · Cited by 10
Sympathetic Activity in Major Depressive Disorder: Identifying Those at Increased Cardiac Risk?
Lambert, G. W., Barton, D., Dawood, T., Lambert, É., Esler, M., Haikerwal, D., Brenchley, C., Socratous, F., Kaye, D. M., Schlaich, M. P., et al. (2007) · Australian & New Zealand Journal of Psychiatry · doi:10.1080/14401614070410s167 · Cited by 3
Cited by
2020 International Society of Hypertension Global Hypertension Practice Guidelines
Unger, T., Borghi, C., Charchar, F., Khan, N. A., Poulter, N. R., Prabhakaran, D., Ramirez, A., Schlaich, M., Stergiou, G. S., Tomaszewski, M., et al. (2020) · Hypertension · doi:10.1161/hypertensionaha.120.15026 · Cited by 4,132
2020 International Society of Hypertension global hypertension practice guidelines
Unger, T., Borghi, C., Charchar, F., Khan, N. A., Poulter, N. R., Prabhakaran, D., Ramirez, A., Schlaich, M., Stergiou, G. S., Tomaszewski, M., et al. (2020) · Journal of Hypertension · doi:10.1097/hjh.0000000000002453 · Cited by 1,283
Mazereel, V., Detraux, J., Vancampfort, D., van Winkel, R., & De Hert, M. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.573479 · Cited by 205
Zhang, M., Chen, J., Yin, Z., Wang, L., & Peng, L. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01759-z · Cited by 172
Self-citationContaminants of emerging concern in freshwater fish from four Spanish Rivers
Pico, Y., Belenguer, V., Corcellas, C., Diaz-Cruz, M. S., Eljarrat, E., Farré, M., Gago-Ferrero, P., Huerta, B., Navarro-Ortega, A., Petrovic, M., et al. (2019) · Science of The Total Environment · doi:10.1016/j.scitotenv.2018.12.366 · Cited by 154
Metadata
- Authors
- Zhong, Z., Wang, L., Wen, X., Liu, Y., Fan, Y., & Liu, Z.
- Affiliations
- The People's Hospital of Guangxi Zhuang Autonomous Region (CN)
- Guangdong General Hospital (CN)
- Guangzhou First People's Hospital (CN)
- Sun Yat-sen University (CN)
- Corresponding author
- Liu, Zhonglin
- Venue
- Neuropsychiatric Disease and Treatment
- Publisher
- Informa UK Limited
- Published
- 2017-11
- Volume
- Volume 13
- Pages
- 2781-2796
- ISSN
- 1176-6328 (ISSN-L)
- 1178-2021
- PMC
- PMC5683798
- OpenAlex
- W2767504574
- Cited by
- 46
- References
- 63
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 8 · 2023: 4 · 2022: 8 · 2021: 6 · 2020: 7 · 2019: 4 · 2018: 3
- FWCI
- 0.49
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Neuropsychiatric Disease and Treatment (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Dove Medical Press (Taylor and Francis Group) (submittedVersion, cc-by-nc)
- Funders
- Science and Technology Planning Project of Guangdong Province (KLB09001, 2014A020212148)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Health and Mental Health
- Keywords
- selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors, blood pressure, depression treatment, antidepressants, systolic blood pressure, diastolic blood pressure
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.